Previous Page  8 / 10 Next Page
Information
Show Menu
Previous Page 8 / 10 Next Page
Page Background

allied

academies

Page 21

Notes:

Journal of Dermatology Research and Skin Care | Volume 3

Dermatol Res Skin Care, Volume 3

September 09-10, 2019 | Edinburgh, Scotland

2

nd

Global Summit on

3

rd

International Conference on

Dermatology and Cosmetology

Wound Care, Tissue Repair and Regenerative Medicine

Joint Event

&

P

soriasis is a chronic immune-mediated inflammatory

skin disease that appears in about 3% of the general

population. In approximately one third of the cases it begins

in childhood or adolescence. As in adults, also in children

plaque-type psoriasis is themost common type of the disease.

Guttate form is the second most common type of psoriasis in

this age group, mostly followed by streptococcal infection. Up

to 71% of children have a positive family history of psoriasis.

As in adulthood also paediatric psoriasis can been associated

with certain comorbidities, such as obesity, hypertension,

hyperlipidemia, diabetes mellitus and rheumatoid arthritis.

Treatment of the disease is determined based on the

severity of the disease and especially in childhood remains a

challenge. In moderate to severe form of childhood psoriasis,

where topical therapy is not effective in the long run, narrow

band UVB and systemic therapy (methotrexate as most often

prescribed) can be valuable, safe and effective way of the

therapy. However, more evidence based data is needed about

effectivenessandlong-termsafetyofsuchtherapiesinchildren.

Speaker Biography

Mateja Starbek graduated medicine in 2000 at the Medical faculty,

University of Ljubljana. In 2006 she obtained a master's degree in

Biomedicine, in 2010 specialisation in Dermatovenereology and in 2018

PhD in the field of Biomedicine. She is Head of Children's department

in Dermatovenereology Clinic of University Medical Centre Ljubljana

and takes part in teaching process as assistant at Medical faculty,

University of Ljubljana. She is one of the leading dermatologists in the

field of paediatric dermatology and psoriasis in Slovenia and one of the

lecturers of the School of Paediatric Dermatology, Atopic Dermatitis

and in the School of patients with psoriasis treated with biologic

drugs. She is a member of the European Academy of Dermatology and

Venereology (EADV), European Society for Paediatric Dermatology

(ESPD) and the Association of Slovenian Dermatovenereologists (ZSD).

e:

matejastarbekzorko@gmail.com

Mateja Starbek

University Medical Centre Ljubljana, Slovenia

Psoriasis of childhood and adolescence